Delivery Order SPE2DB22D3301-SPE2DB26FX4DR
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $5,543.64. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by October 16, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 15, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a contract ceiling value of $23,977.17. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded procurement. The order is scheduled for completion by August 18, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 23, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $6,972.95. This firm fixed-price delivery order is scheduled for completion by October 24, 2025, and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award utilizes no set-aside designation, indicating the contract was competitively awarded among qualified...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 18, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $8,588.52. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The order is scheduled for ultimate completion by August 19, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $1,864.56. This firm fixed-price delivery order, with an ultimate completion date of October 27, 2025, represents a continuation of AmerisourceBergen's pharmaceutical supply support under its existing contract vehicle with DLA. The award was made through open competition with no set-aside designation, reflecting...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $10,280.04. This firm fixed-price delivery order, which has no set-aside designation, is scheduled for completion by November 3, 2025, and will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. The award represents a competitive procurement action under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Jardiance 10 mg tablets (90-count units) under a firm fixed-price contract with a ceiling value of $11,531.50. The delivery order, which is non-set-aside and competitively awarded, is scheduled for completion by November 3, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Jardiance 25 mg tablets (90-count packages) with a ceiling value of $6,717.68. This is a firm fixed-price delivery order with no set-aside designation, completed competitively through open procurement. The order is scheduled for ultimate completion on August 15, 2025, and will be fulfilled at the contractor's facility in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 26, 2025, for the supply of Jardiance 10 mg tablets (90-count units) with a ceiling value of $4,000.90. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is scheduled for completion by September 29, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 4, 2025, for the supply of Jardiance 10 mg tablets (90-count) with a ceiling value of $6,657.98. This is a firm fixed price delivery order with no set-aside designation, indicating the award was made through open competition. The order is set for completion by September 5, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. This delivery order...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB26FX4DRDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 31, 2025, for the supply of Jardiance 10 mg tablets (90-count packages) with a ceiling value of $4,171.18. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement. The contract specifies an ultimate completion date of November 3, 2025, and performance will take place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is executed under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The parent IDC serves as a comprehensive pharmaceutical support vehicle providing global medical supply capabilities to military healthcare systems, including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen, a major pharmaceutical distributor and critical vendor for federal medical procurement, maintains an extensive portfolio of brand-name and generic medications across multiple therapeutic domains under this prime contract vehicle.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $4.2k | 10/31/25 |